Skip to main content
European Spine Journal logoLink to European Spine Journal
. 2001 Jun 14;10(Suppl 2):S205–S213. doi: 10.1007/s005860100308

Bone substitutes in vertebroplasty

P Heini 1, U Berlemann 1
PMCID: PMC3611557  PMID: 11716020

Abstract.

Vertebroplasty – percutaneous cement augmentation of vertebral bodies – is an efficient procedure for the treatment of painful vertebral fractures in osteoporosis. At the present time, polymethylmethacrylate (PMMA) is the only available cement with reports of clinical application and experience. The material is easy to handle, the radiopacity can be adapted by adding contrast dye, and it is mechanically efficient. Composite cements (acrylic cements in conjunction with ceramics) are bioactive, highly radiopaque, and feature excellent mechanical properties. One such cement, Cortoss, is currently undergoing clinical trials for vertebroplasty and has so far been shown to be a potentially valuable alternative to PMMA. Several in vitro studies with injectable calcium phosphate (CaP) cements show their feasibility and mechanical effectiveness. Animal studies confirm their biocompatibility and osteoconductivity. However, handling problems and the limited radiopacity of these cements currently preclude their clinical use.

Keywords: Vertebroplasty Polymethylmethacrylate Osteoporosis Bone cement Calcium phosphate Bone substitutes

Full Text

The Full Text of this article is available as a PDF (109.6 KB).

Footnotes

Electronic Publication


Articles from European Spine Journal are provided here courtesy of Springer-Verlag

RESOURCES